We are live on
!
Find out more
WA
Wilshire Advisors Portfolio holdings
AUM
$9.96M
1-Year Est. Return
76.57%
This Fund
S&P 500
This Quarter
Est. Return
-3.25%
1 Year Est. Return
+76.57%
3 Year Est. Return
+100.3%
5 Year Est. Return
+82.67%
10 Year Est. Return
+137%
AUM
$274M
AUM Growth
+$65.6M
(+32%)
Cap. Flow
+$74.3M
Cap. Flow
% of AUM
27.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
7
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$23M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$17.4M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$15.3M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$9.12M |
| 5 |
iShares Global REIT ETF
REET
|
+$5.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$40.1K |
| 2 |
loanDepot
LDI
|
+$17.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.04% |
| 2 | Financials | 0.01% |
Similar funds
PA
BS
RG
MP
CCM
DFA
AIA
FRT
Wilshire Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Wilshire Advisors held 11 positions worth $274M, up 32% from $208M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Wilshire Advisors deployed $74.3M of net new capital in Q4 2024, adding to 7 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 0.04% of assets, up from 0.03% a quarter earlier, followed by Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $40.1K trimmed.
- Wilshire Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $23M increase.
- Wilshire Advisors's biggest Q4 2024 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $40.1K.
- Wilshire Advisors's ten largest holdings make up 100% of its $274M portfolio in Q4 2024.
- Wilshire Advisors opened 0 new positions and closed 0 in Q4 2024.
- Wilshire Advisors's portfolio value rose 32% quarter-over-quarter to $274M.
Based on Wilshire Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.